Stanley Laman Group, Ltd. Stryker Corp Transaction History

Stanley Laman Group, Ltd.

$648 Million
Q3 2024

A detailed history of Stanley Laman Group, Ltd. transactions in Stryker Corp stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 1,379 shares of SYK stock, worth $495,074. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,379

Previous 752 83.38%

Holding current value

$495,074

Previous $255,000 95.29%

% of portfolio

0.08%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$315.94 - $371.96 $198,094 - $233,218	627 Added 83.38%	1,379 $498,000
Q2 2024 Jul 18, 2024	BUY	$324.3 - $354.67 $10,701 - $11,704	33 Added 4.59%	752 $255,000
Q4 2023 Feb 02, 2024	SELL	$253.85 - $299.46 $8,884 - $10,481	-35 Reduced 4.64%	719 $215,000
Q2 2023 Aug 08, 2023	SELL	$271.49 - $305.09 $68,143 - $76,577	-251 Reduced 24.98%	754 $230,000
Q1 2023 Apr 17, 2023	SELL	$246.13 - $285.47 $2.63 Million - $3.05 Million	-10,691 Reduced 91.41%	1,005 $286,000
Q4 2022 Jan 19, 2023	BUY	$205.51 - $253.93 $255,448 - $315,634	1,243 Added 11.89%	11,696 $0
Q3 2022 Oct 18, 2022	BUY	$189.27 - $231.83 $73,436 - $89,950	388 Added 3.85%	10,453 $2.12 Million
Q2 2022 Aug 08, 2022	BUY	$194.09 - $276.37 $30,472 - $43,390	157 Added 1.58%	10,065 $2 Million
Q1 2022 Apr 21, 2022	BUY	$245.33 - $277.77 $176,146 - $199,438	718 Added 7.81%	9,908 $2.65 Million
Q4 2021 Jan 25, 2022	BUY	$236.63 - $276.44 $2.17 Million - $2.54 Million	9,190 New	9,190 $2.46 Million
Q2 2020 Jul 20, 2020	SELL	$144.67 - $207.03 $228,144 - $326,486	-1,577 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$126.5 - $225.1 $199,490 - $354,982	1,577 New	1,577 $263,000

Others Institutions Holding SYK

# of Institutions

2,171

Shares Held

286M

Call Options Held

1.13M

Put Options Held

1.1M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Account

Stanley Laman Group, Ltd. Stryker Corp Transaction History